Walsh EM, Gucalp A, Patil S, Edelweiss M, et al. Adjuvant enzalutamide for the treatment of early-stage androgen-receptor positive, triple-negative breast cancer: a feasibility study. Breast Cancer Res Treat 2022 Aug 20. pii: 10.1007/s10549-022-06669.
PMID: 35986801